ALLERGAN INC
10-Q, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: ALLERGAN INC, 10-Q, EX-10.5, 2000-08-11
Next: ALLERGAN INC, S-8, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         302,400
<SECURITIES>                                         0
<RECEIVABLES>                                  289,900
<ALLOWANCES>                                     6,900
<INVENTORY>                                    120,700
<CURRENT-ASSETS>                               834,000
<PP&E>                                         632,500
<DEPRECIATION>                                 297,200
<TOTAL-ASSETS>                               1,470,200
<CURRENT-LIABILITIES>                          383,600
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         1,300
<OTHER-SE>                                     746,400
<TOTAL-LIABILITY-AND-EQUITY>                 1,470,200
<SALES>                                        404,100
<TOTAL-REVENUES>                               417,900
<CGS>                                          112,200
<TOTAL-COSTS>                                  125,200
<OTHER-EXPENSES>                                50,900
<LOSS-PROVISION>                                   167
<INTEREST-EXPENSE>                               5,500
<INCOME-PRETAX>                                 74,300
<INCOME-TAX>                                    22,300
<INCOME-CONTINUING>                             51,900
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    51,900
<EPS-BASIC>                                       0.40
<EPS-DILUTED>                                     0.39


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission